Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study.
Savulescu C, Krizova P, Valentiner-Branth P, Ladhani S, Rinta-Kokko H, Levy C, Mereckiene J, Knol M, Winje BA, Ciruela P, de Miguel S, Guevara M, MacDonald L, Kozakova J, Slotved HC, Fry NK, Pekka Nuorti J, Danis K, Corcoran M, van der Ende A, Vestrheim DF, Munoz-Almagro C, Sanz JC, Castilla J, Smith A, Colzani E, Pastore Celentano L, Hanquet G; SpIDnet VE study group. Savulescu C, et al. Among authors: ciruela p. Vaccine. 2022 Jun 23;40(29):3963-3974. doi: 10.1016/j.vaccine.2022.05.011. Epub 2022 May 28. Vaccine. 2022. PMID: 35637067
[Impact of 7-valent pneumococcal conjugate vaccination in a population with low to intermediate vaccination levels].
Salleras L, Domínguez A, Ciruela P, Izquierdo C, Borràs E; Grupo de Trabajo del Sistema de Notificación Microbiológica de Cataluña. Salleras L, et al. Among authors: ciruela p. Enferm Infecc Microbiol Clin. 2009 May;27(5):275-7. doi: 10.1016/j.eimc.2008.09.010. Epub 2009 Apr 22. Enferm Infecc Microbiol Clin. 2009. PMID: 19386393 Spanish.
Changes in serotypes causing invasive pneumococcal disease (2005-2007 vs. 1997-1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine.
Salleras L, Domínguez A, Ciruela P, Izquierdo C, Navas E, Torner N, Borras E. Salleras L, et al. Among authors: ciruela p. Clin Microbiol Infect. 2009 Nov;15(11):997-1001. doi: 10.1111/j.1469-0691.2009.02938.x. Epub 2009 Aug 18. Clin Microbiol Infect. 2009. PMID: 19689466 Free article.
Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.
Muñoz-Almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolome R, Sauca G, Gallés C, Morta M, Ballester F, Raga X, Selva L; Catalan study group of invasive pneumococcal disease. Muñoz-Almagro C, et al. Among authors: ciruela p. J Infect. 2011 Aug;63(2):151-62. doi: 10.1016/j.jinf.2011.06.002. Epub 2011 Jun 12. J Infect. 2011. PMID: 21679725
Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.
Domínguez A, Ciruela P, García-García JJ, Moraga F, de Sevilla MF, Selva L, Coll F, Muñoz-Almagro C, Planes AM, Codina G, Jordán I, Esteva C, Hernández S, Soldevila N, Cardeñosa N, Batalla J, Salleras L. Domínguez A, et al. Among authors: ciruela p. Vaccine. 2011 Nov 8;29(48):9020-5. doi: 10.1016/j.vaccine.2011.09.034. Epub 2011 Sep 20. Vaccine. 2011. PMID: 21939724
Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR.
Selva L, Ciruela P, Esteva C, de Sevilla MF, Codina G, Hernandez S, Moraga F, García-García JJ, Planes A, Coll F, Jordan I, Cardeñosa N, Batalla J, Salleras L, Dominguez A, Muñoz-Almagro C. Selva L, et al. Among authors: ciruela p. Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1487-95. doi: 10.1007/s10096-011-1468-7. Epub 2011 Nov 4. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22052607
73 results